Detecting HPV DNA in Anal and Cervical Cancers
NCT04857528 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2026-03-04
Summary
This is a research study for individuals who have cancer associated with human papillomavirus (HPV) and are being treated with radiation as part of standard care for their cancer. Doctors leading this study will use blood tests to find out if they can detect the HPV virus in the blood of study participants before, during, and after radiation treatment. They will also collect blood and archival tumor tissue (from a previous biopsy) to perform other tests in the future that could provide more information about HPV-associated cancers and how they respond to treatment. Participation in this study will last approximately 2 years.
Conditions
- Cervical Cancer
- Anal Cancer
- HPV-Related Anal Squamous Cell Carcinoma
- HPV-Related Cervical Carcinoma
- HPV-Related Carcinoma
- Uterine Cervical Cancer
Interventions
- RADIATION
-
Radiation Treatment With or Without Chemotherapy
Standard care radiation treatment.
- OTHER
-
Blood Sample Collection
Researchers will collect blood samples from participants before, during and after radiation treatment. Approximately 6 teaspoons of blood will be collected each time blood is drawn.
- DIAGNOSTIC_TEST
-
HPV Genotyping (HPV DNA Test)
A test used to detect the type of HPV DNA found in the participant's blood and tumor tissue samples.
- DIAGNOSTIC_TEST
-
Testing Archival Tumor Tissue
Tumor tissue will be tested in a lab for all cervical cancer participants and some participants with anal cancer as assessed by the lead study doctor. This tumor tissue sample will be from a previous biopsy that the participant received before the study per standard care; no new biopsy will be required for this study.
- OTHER
-
Physical Exam
A physical exam will be given 12 months after radiation treatment. This physical exam may also include an anoscopy (a procedure to examine the anus using a device inserted into the anus) or sigmoidoscopy (a procedure that looks at the rectum and lower part of the colon using a device inserted into the anus).
- DIAGNOSTIC_TEST
-
Positron Emission Tomography Scan (PET Scan)/ Computed Tomography Scan (CT Scan)
Tests that use computers and/or rotating x-rays to scan/create images of the body.
Sponsors & Collaborators
-
University of Chicago
lead OTHER
Principal Investigators
-
Christina Son, MD · University of Chicago
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-10-06
- Primary Completion
- 2027-11-15
- Completion
- 2027-11-15
Countries
- United States
Study Locations
More Related Trials
-
Self-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer Prevention
NCT01014026 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Using Human Papillomavirus (HPV) DNA Testing to Detect HPV-Related Oropharyngeal Cancer (OPC)
NCT05814549 ·Status: ACTIVE_NOT_RECRUITING
-
Clinical, Translational and Biomarker-Based Female Genital HPV Induced Dysplasia and Cancer Screening Study Using Cf-HPV-DNA Blood Tests
NCT05536843 ·Status: UNKNOWN
-
Improving Detection and Early Action for HPV-positive Oropharynx Cancer
NCT04871490 ·Status: COMPLETED ·Phase: NA
-
Screen and Treat for Cervical Cancer Prevention
NCT00233727 ·Status: TERMINATED ·Phase: PHASE3
-
Evaluation of First-void Urine as an Alternative to Cervical Sampling for Human Papillomavirus (HPV) Testing in Cervical Cancer Screening (Single-center Study).
NCT06254846 ·Status: RECRUITING ·Phase: NA
-
Screening Women With Prior HPV for Anal Neoplasia
NCT05217940 ·Status: RECRUITING ·Phase: NA
-
HPV Integration and Tumorigenesis of Uterine Cervical Adenocarcinoma
NCT03742869 ·Status: UNKNOWN
-
Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial
NCT04679675 ·Status: COMPLETED ·Phase: NA
-
Early Warning Model of Susceptibility and High-risk Population of Cervical Cancer Related to HPV
NCT04974424 ·Status: UNKNOWN
-
Post-treatment Surveillance in HPV+ Oropharyngeal SCC
NCT04965792 ·Status: ACTIVE_NOT_RECRUITING
-
Urinary and Vaginal HPV Testing in Cervical Cancer Screening
NCT05065853 ·Status: UNKNOWN
-
Multilevel HPV Self-Testing Intervention for the Increase of Cervical Cancer Screening Among Women in Appalachia
NCT04411849 ·Status: COMPLETED ·Phase: NA
-
A Multicenter Cohort Study of HPV Viral Load in Predicting the Postoperative Recurrence of HSIL
NCT05282745 ·Status: RECRUITING
-
HPV Serum Level and FDG PET CT in Patients With Cervical Cancer Treated With Radical Radiochemotherapy
NCT04683549 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
DNA Analysis of Tumor Tissue Samples From Patients With Human Papilloma Virus-Associated Cancer of the Oropharynx
NCT00897988 ·Status: COMPLETED
-
HPV Self-testing in Transgender Individuals
NCT05883111 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
DNA Methylation and the Increased Risk of Cervical Cancer Development
NCT06859151 ·Status: NOT_YET_RECRUITING
-
HPV Genotyping by DR. HPV Genotyping in Vitro Diagnostic Device (IVD) Kit in Exfoliated Cells of the Uterine Cervix
NCT04333212 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Initial High Risk Human Papillomavirus (HR-HPV) Viral Load as Predictive Marker for Cervical Intraepithelial Neoplasia Grade 1 (CIN1) Persistence
NCT00682552 ·Status: TERMINATED ·Phase: NA
-
Identifying Genes That Predict Risk of Developing Cervical Intraepithelial Neoplasia or Invasive Cervical Cancer
NCT00458562 ·Status: COMPLETED
-
HPV Integration Testing for Human Papillomavirus-Positive Women
NCT02576262 ·Status: UNKNOWN
-
Prevaccination Study of Cervical Human Papillomavirus Types in Yangtze River Delta Area, China
NCT01487681 ·Status: UNKNOWN
-
DNA Methylation for Screening Uterine Cervical Lesions
NCT03960879 ·Status: UNKNOWN
-
Blood Biomarkers Based Screening for HPV-driven OPC
NCT06528353 ·Status: NOT_YET_RECRUITING ·Phase: NA